Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Healthcare
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the... see more

Recent & Breaking News (TSX:CPH)

Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Newsfile 13 days ago

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results

Canada NewsWire March 14, 2024

Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call

Canada NewsWire March 8, 2024

Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading

Canada NewsWire January 29, 2024

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

GlobeNewswire January 29, 2024

Cipher Pharmaceuticals Announces Change of Auditor

Canada NewsWire November 24, 2023

Cipher Pharmaceuticals Announces Normal Course Issuer Bid

Canada NewsWire November 15, 2023

Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023

Canada NewsWire November 9, 2023

Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call

Canada NewsWire October 27, 2023

Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid

Canada NewsWire October 12, 2023

Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid

Canada NewsWire October 3, 2023

Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars

Canada NewsWire September 5, 2023

Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico

Canada NewsWire August 10, 2023

Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call

Canada NewsWire July 28, 2023

Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union

Canada NewsWire July 5, 2023

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

Canada NewsWire June 21, 2023

Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility

Canada NewsWire May 11, 2023

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call

Canada NewsWire May 4, 2023

Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Newsfile April 18, 2023

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

Canada NewsWire March 16, 2023